C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 307/10 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) A61P 25/28 (2006.01) A61P 35/00 (2006.01) C07D 213/40 (2006.01) C07D 265/10 (2006.01) C07D 277/28 (2006.01) C07D 285/16 (2006.01) C07D 295/22 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2618013
The invention relates to the substituted 1,2-ethylenediamines of general formula (I), wherein the groups R1 to R13, A, B, L and i are defined as in the description and the claims. The invention also relates to the use thereof in the treatment of Alzheimer's disease (AD) and similar diseases.
La présente invention concerne des 1,2-éthylènediamines de formule générale (I) dans laquelle les radicaux R1 à R13, A, B, L et i sont tels que définis dans la description et les revendications, et l'utilisation desdites substances pour traiter la maladie d'Alzheimer (AD) et des pathologies similaires.
Dorner-Ciossek Cornelia
Eickmeier Christian
Fuchs Klaus
Handschuh Sandra
Heine Niklas
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Beta-secretase inhibitors for use in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-secretase inhibitors for use in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-secretase inhibitors for use in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1841938